Related Experiment Videos
Effect of oxatomide on otitis media with effusion--an experimental study
T Tanaka1, Y Kurono, H Kawauchi
1Department of Otolaryngology, Oita Medical University, Japan.
Acta Oto-Laryngologica
|July 1, 1995
Summary
Oxatomide effectively treats experimental otitis media with effusion (OME) by reducing inflammation and leukotriene levels. This drug, administered orally, shows promise for managing OME in patients.
Area of Science:
- Pharmacology
- Otolaryngology
- Immunology
Background:
- Otitis media with effusion (OME) is a common condition often linked to immune responses.
- Investigating novel therapeutic agents for OME is crucial for improving patient outcomes.
Purpose of the Study:
- To evaluate the therapeutic efficacy of oxatomide in a chinchilla model of experimental OME.
- To assess the impact of oxatomide on inflammatory mediators in middle ear effusion.
Main Methods:
- Experimental OME was induced by keyhole limpet hemocyanin (KLH) in chinchillas.
- Oxatomide was administered orally at varying doses (5, 10, 30 mg/kg) for two weeks.
- OME severity was evaluated using surgical microscopy, tympanography, histology, and leukotriene measurements.
Main Results:
- Oral oxatomide at 10 and 30 mg/kg significantly alleviated experimental OME.
- The 30 mg/kg dose of oxatomide markedly reduced leukotriene D4 (LTD4) concentrations in middle ear effusion.
- Pharmacokinetic analysis confirmed rapid absorption and middle ear penetration of oxatomide via circulation.
Conclusions:
- Oxatomide demonstrates significant therapeutic potential for managing otitis media with effusion.
- The anti-inflammatory effects of oxatomide, particularly its impact on leukotrienes, are key to its efficacy in OME.
- These findings support the potential clinical application of oxatomide in treating human OME.